Atlas Trials

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors

Clinical trial NCT01640665 · COMPLETED

Trial details

NCT number
NCT01640665
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast CancerGastrointestinal Tumors
Start date
2012-07-01
Primary completion
2014-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.